Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases

Endocrinology

Volumn 141, Issue 4, 2000, Pages 1289-1300

  Dews, M ^a   Prisco, M ^a   Peruzzi, F ^a   Romano, G ^a   Morrione, A ^a   Baserga, R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MUTANT PROTEIN; PROTEIN SHC; SERINE; SOMATOMEDIN C RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 0034455621     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.4.7414     Document Type: Article

References (54)

1. Association of Grb2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: Implications for Ras activation
2. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation
3. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways
4. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway
5. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation
6. Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor
7. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent
8. The IRS-signalling system: A network of docking proteins that mediate insulin action
9. Role of binding proteins to IRS-1 in insulin signalling
10. How MAP kinases are regulated
11. Insulin signal transduction through protein klnase cascades
12. Insulin regulation of the Ras activation/inactivation cycle
13. IRS-1 essential for insulin- and IL-4-stimulated mitogenesis in hemopoietic cells
14. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal
15. IGFs and cell growth
16. S6K signaling during insulin, insulin-like growth factor-I and interleukin-4 stimulation
17. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
18. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
19. Regulation of neuronal survival by the serine-threonine protein kinase Akt
20. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
21. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion
22. The IGF-I receptor as a physiological relevant target of p53 in apoptosis caused by interleukin-3 withdrawal
23. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis
24. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells
25. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor
26. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain
27. Effects of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor
28. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor
29. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis
30. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling
31. Cytokine dependent granulocytic differentiation
32. Growth and differentiation signals by the insulin-like growth factor receptor in hemopoietic cells are mediated through different pathways
33. Insulin and IGF-I Receptors signaling in protection from apoptosis
34. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins
35. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: Role of receptor number
36. Insulin-like growth factor 1 synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression
37. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
38. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway
39. Overexpression of Shc proteins potentiates the proliferative response to the macrophage-granulocyte colony-stimulating factor and recruitment of Grb2/Sos and Grb2/p140 complexes to the β receptor subunit
40. Non-SH2 domains within insulin receptor substrate-1 and Shc mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor 1 receptor
41. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc and Grbl0
42. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway
43. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor
44. Structure-function relationship of the insulin-like growth factor I receptor tyrosine kinase
45. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-I, and epidermal growth factor
46. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
47. mpkk) in fibroblasts
48. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation
49. 14.3.3 Interacts with the insulin-like growth factor I receptor and insulin receptor substrate 1 in a phosphoserine-dependent manner
50. 14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor
51. 14.3.3β protein associates with insulin receptor substrate-1 and decreases insulin-stimulated phosphatidyilinositol 3′-kinase activity in 3T3L1 adipocytes
52. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function
53. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent
54. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system